Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 4
1952 9
1953 7
1954 22
1955 15
1956 11
1957 18
1958 11
1959 2
1964 10
1965 31
1966 30
1967 67
1968 87
1969 99
1970 92
1971 117
1972 145
1973 177
1974 168
1975 166
1976 163
1977 172
1978 171
1979 188
1980 152
1981 195
1982 208
1983 201
1984 250
1985 239
1986 259
1987 223
1988 231
1989 196
1990 246
1991 240
1992 296
1993 302
1994 376
1995 350
1996 366
1997 318
1998 356
1999 420
2000 445
2001 420
2002 488
2003 521
2004 565
2005 601
2006 635
2007 634
2008 754
2009 847
2010 823
2011 854
2012 913
2013 910
2014 1059
2015 1035
2016 1096
2017 1085
2018 1082
2019 1069
2020 1120
2021 994
2022 856
2023 802
2024 232

Text availability

Article attribute

Article type

Publication date

Search Results

24,783 results

Results by year

Filters applied: . Clear all
Page 1
Safety profile of hypnotics or sedatives on community-dwelling older adults aged 75 or older in Japan: A retrospective propensity-matched cohort study.
Handa N, Ishizaki T, Mitsutake S, Ono K, Akishita M. Handa N, et al. Int J Geriatr Psychiatry. 2024 Apr;39(4):e6085. doi: 10.1002/gps.6085. Int J Geriatr Psychiatry. 2024. PMID: 38622754
Exclusion criteria included co-prescribed medications acting on the central nervous system, diagnoses of malignant neoplasm, dementia, depression, etc. ...The results will help provide guidance on whether it is reasonable to prescribe hypnotics …
Exclusion criteria included co-prescribed medications acting on the central nervous system, diagnoses of malignant
Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents.
Doostmohammadi A, Jooya H, Ghorbanian K, Gohari S, Dadashpour M. Doostmohammadi A, et al. Cell Commun Signal. 2024 Apr 15;22(1):228. doi: 10.1186/s12964-024-01607-9. Cell Commun Signal. 2024. PMID: 38622735 Free PMC article. Review.
In this study, we'll discuss about multi-target drugs, their benefits in improving cancer treatments, and recent advances in the field of multi-targeted drugs. Also, we will study the research that performed clinical trials using multi-target therapeutic agents for cancer …
In this study, we'll discuss about multi-target drugs, their benefits in improving cancer treatments, and recent advances in the field of mu …
Comparative analysis of bevacizumab and LITT for treating radiation necrosis in previously radiated CNS neoplasms: a systematic review and meta-analysis.
Gecici NN, Gurses ME, Kaye B, Jimenez NLF, Berke C, Gökalp E, Lu VM, Ivan ME, Komotar RJ, Shah AH. Gecici NN, et al. J Neurooncol. 2024 Apr 15. doi: 10.1007/s11060-024-04650-1. Online ahead of print. J Neurooncol. 2024. PMID: 38619777 Review.
This study aims to evaluate and compare the efficacy of bevacizumab and laser interstitial thermal therapy (LITT) in treating RN in patients with previously radiated central nervous system (CNS) neoplasms. METHODS: PubMed, Cochrane, Scopus, and EMBASE …
This study aims to evaluate and compare the efficacy of bevacizumab and laser interstitial thermal therapy (LITT) in treating RN in patients …
THE EFFECT OF A MULTIMODAL APPROACH ON THE RESULTS OF TREATMENT IN SURGERY: INTEGRATION OF CHEMOTHERAPY, SURGERY, AND RADIOTHERAPY.
Vovk V, Duda I, Vovk A. Vovk V, et al. Georgian Med News. 2024 Feb;(347):41-46. Georgian Med News. 2024. PMID: 38609112 Review.
This approach is linked to the highest rates of disease-free survival, overall survival, and the lowest complication rates. However, further high-quality randomized trials are necessary to accurately assess the efficacy of this integrated approach in managing various cance …
This approach is linked to the highest rates of disease-free survival, overall survival, and the lowest complication rates. However, further …
[Clinical study of 15 cases of primary non-immunodeficient central nervous system lymphoma in children].
Gao HX, Zhang NN, Zhou CJ, Jin L, Yang J, Huang S, Zhang M, Li N, Zhang YH, Duan YL. Gao HX, et al. Zhonghua Xue Ye Xue Za Zhi. 2024 Feb 14;45(2):190-194. doi: 10.3760/cma.j.cn121090-20230904-00102. Zhonghua Xue Ye Xue Za Zhi. 2024. PMID: 38604797 Chinese.
Clinical data of 15 primary central nervous system lymphoma (PCNSL) children aged 18 years admitted to our hospital between May 2013 to May 2023 were retrospectively analyzed. Our goal was to summarize the clinical features of children and inves
Clinical data of 15 primary central nervous system lymphoma (PCNSL) children aged 18 years admitted to our hospi
Alectinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
Wu YL, Dziadziuszko R, Ahn JS, Barlesi F, Nishio M, Lee DH, Lee JS, Zhong W, Horinouchi H, Mao W, Hochmair M, de Marinis F, Migliorino MR, Bondarenko I, Lu S, Wang Q, Ochi Lohmann T, Xu T, Cardona A, Ruf T, Noe J, Solomon BJ; ALINA Investigators. Wu YL, et al. N Engl J Med. 2024 Apr 11;390(14):1265-1276. doi: 10.1056/NEJMoa2310532. N Engl J Med. 2024. PMID: 38598794 Clinical Trial.
The primary end point was disease-free survival, tested hierarchically among patients with stage II or IIIA disease and then in the intention-to-treat population. Other end points included central nervous system (CNS) disease-free survival, overall survival, …
The primary end point was disease-free survival, tested hierarchically among patients with stage II or IIIA disease and then in the intentio …
Von-Hipple Lindau syndrome with family history: a case report and seventeen years follow-up study.
Fan X, Wang S, Chen T, Hu W, Yang H. Fan X, et al. Front Oncol. 2024 Mar 26;14:1360942. doi: 10.3389/fonc.2024.1360942. eCollection 2024. Front Oncol. 2024. PMID: 38595826 Free PMC article.
BACKGROUND: Von-Hipple Lindau syndrome is an uncommon autosomal dominant disorder. 17 years ago we diagnosed a young woman with VHL syndrome validated by Sanger sequencing, her family members were genetically tested as well, and 187 healthy people were randomly selected fo …
BACKGROUND: Von-Hipple Lindau syndrome is an uncommon autosomal dominant disorder. 17 years ago we diagnosed a young woman with VHL syndrome …
Understanding and Managing Pineal Parenchymal Tumors of Intermediate Differentiation: An In-Depth Exploration from Pathology to Adjuvant Therapies.
Bianconi A, Panico F, Lo Zito B, Do Trinh A, Cassoni P, Ricardi U, Garbossa D, Cofano F, Mantovani C, Bertero L. Bianconi A, et al. J Clin Med. 2024 Feb 23;13(5):1266. doi: 10.3390/jcm13051266. J Clin Med. 2024. PMID: 38592098 Free PMC article. Review.
BACKGROUND: Pineal parenchymal cell tumors constitute a rare group of primary central nervous system neoplasms (less than 1%). Their classification, especially the intermediate subtype (PPTIDs), remains challenging. ...While surgical approaches are sta …
BACKGROUND: Pineal parenchymal cell tumors constitute a rare group of primary central nervous system neoplasms ( …
Ibrutinib disrupts blood-tumor barrier integrity and prolongs survival in rodent glioma model.
Lim S, Kwak M, Kang J, Cesaire M, Tang K, Robey RW, Frye WJE, Karim B, Butcher D, Lizak MJ, Dalmage M, Foster B, Nuechterlein N, Eberhart C, Cimino PJ, Gottesman MM, Jackson S. Lim S, et al. Acta Neuropathol Commun. 2024 Apr 8;12(1):56. doi: 10.1186/s40478-024-01763-6. Acta Neuropathol Commun. 2024. PMID: 38589905 Free PMC article.
In malignant glioma, cytotoxic drugs are often inhibited from accessing the tumor site due to the blood-tumor barrier (BTB). ...
In malignant glioma, cytotoxic drugs are often inhibited from accessing the tumor site due to the blood-tumor barrier (BTB). ...
24,783 results
You have reached the last available page of results. Please see the User Guide for more information.